Bharat Biotech on Thursday released a statement highlighting the safety measures taken during the development of its COVID-19 vaccine amid debate over the side effects of Covishield. The assertion ...
NEW DELHI: Bharat Biotech on Thursday assured Covaxin's safety amid debate over Astrazeneca's admission that its Covid-19 vaccine, sold as Covishield in India, could cause "rare' side effects.
Amid the ongoing debate over the UK-based Covid-19 vaccine manufacturer AstraZeneca's recent admission that its Covid-19 shot, labeled as 'Covishield' in India, could cause 'rare' side effects ...
Amid growing concerns over the side-effects of AstraZeneca's vaccines after the company admitted for the first time that their Covid jabs can cause a rare side effect called Thrombosis with ...
Bharat Biotech on Thursday said that it developed Covaxin with a single-minded focus on safety first, followed by efficacy. In a statement on the ongoing debate on the the side effects of ...
Amid a row over AstraZeneca's admission of potential side effects of its Covid-19 vaccine, Bharat Biotech said that its Covaxin vaccine was developed with a single-minded focus on safety first, ...
Bharat Biotech on Thursday said that it developed Covaxin with a single-minded focus on safety first, followed by efficacy. In a statement on the ongoing debate on the the side effects of ...
During the ongoing debate regarding AstraZeneca’s acknowledgment of “rare” side effects from its Covid-19 vaccine, known as Covishield in India, Bharat Biotech, the developer of Covaxin, highlighted ...
Covishield: కోవిడ్19 టీకా తీసుకున్న వారికి ఇచ్చే కోవిన్ సర్టిఫికేట్లో ఉండే ప్రధాని మోదీ ఫోటోను ఆ ...
The British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca admitted in court papers submitted to a UK court that its COVID vaccine, Covishield, can lead to rare ...